Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels

Molecular Pharmacology

Volumn 58, Issue 3, 2000, Pages 591-600

  Wickenden, Alan D ^a   Yu, Weifeng ^a   Zou, Anrou ^a   Jegla, Tim ^a   Wagoner, P Kay ^a  

^a Icagen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LINOPIRDINE; POTASSIUM CHANNEL; RETIGABINE;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; CELL POLARITY; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPHYSIOLOGY; HYPERPOLARIZATION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL;

EID: 0033862433     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.3.591     Document Type: Article

References (28)

1. Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer
2. Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by 4-aminopyridine in rat entorhinal cortex hippocampal slices
3. A potassium channel mutation in neonatal human epilepsy
4. A pore mutation in an idiopathic epilepsy family
5. Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: Prediction of clinical response
6. ++ model in the hippocampal slice preparation
7. Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches
8. Retigabine strongly reduces repetitive firing in rat entorhinal cortex
9. The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in-vivo
10. Effects of a cognition enhancer, linopirdine (DuP 996) on M-type potassium currents (IK(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons
11. + current due to a novel mutation in KCNQ2 causes neonatal convulsions
12. Anticonvulsant activity of a new drug D-20443
13. Anticonvulsant activity of D-20443
14. + current by linopirdine, a neurotransmitter-release enhancer, in NG108-15 neuronal cells and rat cerebral neurons in culture
15. D-23129: A new anticonvulsant with broad spectrum activity in animal models of epileptic seizures
16. + channels in neuronal cells
17. + channel opening effect of the anticonvulsant retigabine in PC12 cells
18. Multiple actions of the new anticonvulsant D-23129 on voltage-gated inward currents and GABA-induced currents in cultured neuronal cells
19. Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurones
20. + channels causes epilepsy
21. M-channel gating and simulation
22. + channel subunit, Erg-1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell
23. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
24. D-23129: A potent anticonvulsant in the amygdala kindling model of complex partial seizures
25. M-current suppression in PC12 cells by bradykinin is mediated by a pertussis toxin-insensitive G-protein and modulated by intracellular calcium
26. KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel
27. Pharmacological evidence that somatostatin activates the M-current in hippocampal pyramidal neurons
28. Functional expression of two KvLQT-related potassium channels responsible for an inherited idiopathic epilepsy